Print

Fraunhofer USA Center for Molecular Biotechnology Plant Produced H1N1 Vaccine Begins Phase 1 Clinical Trial  
9/20/2010 6:28:58 AM

NEWARK, Del.--(BUSINESS WIRE)--Fraunhofer USA Center for Molecular Biotechnology (CMB) announced today it has initiated the first human trial of plant-produced H1N1 influenza vaccine at the Walter Reed Army Institute of Research Clinical Trials Center (WRAIR-CTC).
//-->